27 research outputs found
Atmospheric neutrino oscillations with three neutrinos and a mass hierarchy
A comprehensive formalism for the description of neutrino oscillations in the
Earth in a general scheme with three massive neutrinos and the mass hierarchy
m_1<<m_2<<m_3 is presented. Using this formalism, which is valid both in vacuum
and in a medium, the matter effect on the oscillations of low-energy neutrinos
is discussed, pointing out the existence of very long oscillations which are
independent of the neutrino masses and the neutrino energy, and are very
sensitive to the matter density along the neutrino trajectory. As an example of
application of the formulation, a fit of the Kamiokande atmospheric neutrino
data with the matter effect taken into account for neutrinos propagating in the
Earth is presented. The results of the fit indicate that 4*10^{-3} eV^2 < m_3^2
nu_e,
nu_munu_tau, nu_enu_tau) could be large. Hence, long-baseline experiments
with reactor (CHOOZ and Palo Verde) and accelerator (K2K, MINOS and ICARUS)
neutrinos could observe neutrino oscillations in all channels with a relatively
large statistics.Comment: 42 pages, including 7 figure
Patterns of anti-malarial drug treatment among pregnant women in Uganda
BACKGROUND: Prompt use of an effective anti-malarial drug is essential for controlling malaria and its adverse effects in pregnancy. The World Health Organization recommends an artemisinin-based combination therapy as the first-line treatment of uncomplicated malaria in the second and third trimesters of pregnancy. The study objective was to determine the degree to which presumed episodes of uncomplicated symptomatic malaria in pregnancy were treated with a recommended anti-malarial regimen in a region of Uganda. METHODS: Utilizing a population-based random sample, we interviewed women living in Jinja, Uganda who had been pregnant in the past year. RESULTS: Self-reported malaria during the index pregnancy was reported among 67% (n = 334) of the 500 participants. Among the 637 self-reported episodes of malaria, an anti-malarial drug was used for treatment in 85% of the episodes. Use of a currently recommended treatment in the first trimester was uncommon (5.6%). A contraindicated anti-malarial drug (sulphadoxine-pyrimethamine and/or artemether-lumefantrine) was involved in 70% of first trimester episodes. Recommended anti-malarials were used according to the guidelines in only 30.1% of all second and third trimester episodes. CONCLUSIONS: Self-reported malaria was extremely common in this population and adherence to treatment guidelines for the management of malaria in pregnancy was poor. Use of artemether-lumefantrine combined with non-recommended anti-malarials was common practice. Overuse of anti-malarial drugs, especially ones that are no longer recommended, undermines malaria control efforts by fueling the spread of drug resistance and delaying appropriate treatment of non-malarial febrile illnesses. Improved diagnostic capacity is essential to ultimately improving the management of malaria-like symptoms during pregnancy and appropriate use of currently available anti-malarials